Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer
<p>We sought information worldwide on mortality according to assigned treatment in all randomized trials that began before 1985 of adjuvant tamoxifen or cytotoxic therapy for early breast cancer (with or without regional lymph-node involvement). Coverage was reasonably complete for most countr...
Autor principal: | Early Breast Cancer Trialists' Collaborative Group |
---|---|
Outros Autores: | Henderson, I |
Formato: | Journal article |
Idioma: | English |
Publicado em: |
Massachusetts Medical Society
1988
|
Registros relacionados
-
Tamoxifen for early breast cancer: an overview of the randomised trials
por: Early Breast Cancer Trialists' Collaborative Group
Publicado em: (1998) -
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials
por: Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
Publicado em: (2011) -
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials
por: Early Breast Cancer Trialists’ Collaborative Group
Publicado em: (2017) -
Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: patient level meta-analysis of 7,030 women in four randomised trials
por: Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
Publicado em: (2022) -
Effects of radiotherapy and surgery in early breast cancer: an overview of the randomized trials
por: Early Breast Cancer Trialists' Collaborative Group
Publicado em: (1995)